A Type 1 Diabetes Lifestyle Website
Drug and device maker Abbott has won approval from the U.S. Food and Drug Administration (FDA) for its next generation FreeStyle Libre 2 iCGM system for adults and children ages 4 and older with diabetes. While there are other iCGM (integrated continuous glucose monitor) systems currently on the market, including an older version of the […]
CHICAGO — Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters. Abbott executives said the increase in manufacturing capacity will begin in the second half of […]
L’INESSS (Institut national d’excellence en santé et en services sociaux) recommande au ministre d’inscrire le Système flash de surveillance du glucose (FreeStyle LibreMD, Abbott) sur la Liste des médicaments du RGAM (régime général d’assurance médicament) pour l’autosurveillance de la glycémie chez les patients traités par insulinothérapie, selon certaines conditions. Cliquez ici pour continuer –> Diabete.qc.ca
Sports were always a tricky proposition for 11-year-old Noah Copeland. Diagnosed with Type 1 diabetes at age 3, he had to carefully monitor his blood sugar levels with any sort of activity. If he suspected his blood sugars might be getting too low during a soccer game, he would have to leave the field and […]
Coinciding with World Diabetes Day, the National Health Service (NHS) in England is providing funding for Flash Glucose Monitors (FGM) for Type 1 Diabetic (T1D) patients. The move is set to change the lives of tens of thousands of people in the country. Read more –> Forbes.com
Abbott’s ever popular Libre FreeStyle has a follow up! The 2nd generation Libre was just approved in Europe. Check out the press release